These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448 [TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718 [TBL] [Abstract][Full Text] [Related]
7. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836 [TBL] [Abstract][Full Text] [Related]
8. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion]. Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584 [TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451 [TBL] [Abstract][Full Text] [Related]
10. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T; Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results. Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129 [TBL] [Abstract][Full Text] [Related]
12. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy. Song S; Song C; Kim HJ; Wu HG; Kim JH; Park NH; Song YS; Kim JW; Kang SB; Ha SW Gynecol Oncol; 2012 Jan; 124(1):63-7. PubMed ID: 22004904 [TBL] [Abstract][Full Text] [Related]
13. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643 [TBL] [Abstract][Full Text] [Related]
14. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer. Chen SW; Liang JA; Yang SN; Hung YC; Yeh LS; Shiau AC; Lin FJ Gynecol Oncol; 2004 Oct; 95(1):208-14. PubMed ID: 15385134 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer. Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087 [TBL] [Abstract][Full Text] [Related]
16. Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients. Schwarz JK; Wahab S; Grigsby PW Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1258-63. PubMed ID: 20932657 [TBL] [Abstract][Full Text] [Related]
17. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Serkies K; Jassem J Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198 [TBL] [Abstract][Full Text] [Related]
18. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer. Kawase S; Okuda T; Ikeda M; Ishihara S; Itoh Y; Yanagawa S; Ishigaki T Gynecol Oncol; 2006 Sep; 102(3):493-9. PubMed ID: 16478629 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655 [TBL] [Abstract][Full Text] [Related]
20. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]